Interleukin-1/6 Blockade for the Treatment of Severe Steroid-Refractory BNT162b2 Vaccine-Induced Adult-Onset Still’s Disease
Introduction: Several immune-mediated side effects have been reported with COVID-19 vaccines, including myocarditis. Case description: A 27-year-old woman with a past medical history of mild COVID-19, developed adult-onset Still’s disease (AOSD) with salmon-pink flagellate erythema, polyarthritis,...
Main Authors: | Benjamin Hugues, Hakim Ben Amer, Floriane Bril, Matthieu Groh, Florent Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2022-08-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/3469 |
Similar Items
-
Flagellate dermatitis: An atypical skin finding in adult‐onset Still's disease
by: Sana Toujani, et al.
Published: (2022-10-01) -
Different Features of Interleukin-37 and Interleukin-18 as Disease Activity Markers of Adult-Onset Still’s Disease
by: Seoung Wan Nam, et al.
Published: (2021-02-01) -
Atypical Adult-onset Still's disease with flagellate morphology in a patient with skin of color
by: Paayal Vora, BS, et al.
Published: (2023-07-01) -
Distinct Effects of Interleukin-1β Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab
by: Khetam Ghannam, et al.
Published: (2021-09-01) -
Case report: Coronavirus Disease 2019 (COVID-19) modified RNA vaccination-induced Adult-Onset Still's Disease with fulminant myocarditis as initial presentation
by: Mi Zhou, et al.
Published: (2023-03-01)